BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3287971)

  • 21. Single-center study results of cefotetan and cefoxitin prophylaxis for abdominal or vaginal hysterectomy.
    Orr JW; Sisson PF; Barrett JM; Ellington JR; Jennings RH; Taylor DL
    Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):714-6. PubMed ID: 3128114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-dose cefotetan versus multiple-dose cefoxitin as prophylaxis in colorectal surgery.
    Jagelman DG; Fabian TC; Nichols RL; Stone HH; Wilson SE; Zellner SR
    Am J Surg; 1988 May; 155(5A):71-6. PubMed ID: 3287972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Moxalactam in complications of abdominal surgery].
    Dupeyron JP; Peter JD; Rigolot JC
    Sem Hop; 1983 Jun; 59(26):1985-9. PubMed ID: 6310792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Third-generation cephalosporins for polymicrobial surgical sepsis.
    Stone HH; Strom PR; Fabian TC; Dunlop WE
    Arch Surg; 1983 Feb; 118(2):193-200. PubMed ID: 6295339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-dose cefotetan versus multidose cefoxitin for prophylaxis in cesarean section in high-risk patients.
    McGregor JA; French JI; Makowski E
    Am J Obstet Gynecol; 1986 Apr; 154(4):955-60. PubMed ID: 3515951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moxalactam versus gentamicin-clindamycin in surgical sepsis. Efficacy and safety.
    Stone HH; Kolb L; Geheber CE
    Schweiz Rundsch Med Prax; 1983 Mar; 72(11):351-5. PubMed ID: 6221242
    [No Abstract]   [Full Text] [Related]  

  • 27. Analysis of prothrombin time prolongation in North American cefotetan clinical trials: questions and answers.
    Goldstein NH
    Am J Surg; 1988 May; 155(5A):44-6. PubMed ID: 3287967
    [No Abstract]   [Full Text] [Related]  

  • 28. Moxalactam in the treatment of intraabdominal sepsis and other surgical infections.
    Busuttil RW; McGrattan MA; Winston DJ
    Rev Infect Dis; 1982; 4 Suppl():S676-82. PubMed ID: 6218582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient stratification in intra-abdominal infection.
    Wittmann DH; Müller M
    Chemioterapia; 1987 Jun; 6(2 Suppl):460-2. PubMed ID: 3509471
    [No Abstract]   [Full Text] [Related]  

  • 30. [Should cefminox substitute cefoxitin in infections caused by bacteria susceptible to both drugs?].
    Dámaso D; Burillo A; Rogero G; Losada I
    Rev Esp Quimioter; 1999 Dec; 12(4):325-31. PubMed ID: 10855011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cefotetan, Apatef].
    Friis H; Moesgaard F
    Ugeskr Laeger; 1987 Aug; 149(36):2408-10. PubMed ID: 3329791
    [No Abstract]   [Full Text] [Related]  

  • 32. Results of a single-center study of cefotetan prophylaxis in abdominal or vaginal hysterectomy.
    Gordon SF
    Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):710-4. PubMed ID: 3128113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacoeconomic analysis of ampicillin-sulbactam versus cefoxitin in the treatment of intraabdominal infections.
    Messick CR; Mamdani M; McNicholl IR; Danziger LH; Rodvold KA; Condon RE; Walker AP; Edmiston CE
    Pharmacotherapy; 1998; 18(1):175-83. PubMed ID: 9469691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cefotetan (Cefotan): a new cephalosporin.
    Ahmed ME; May G; Branch RA
    Ration Drug Ther; 1986 Dec; 20(12):1-5. PubMed ID: 3303125
    [No Abstract]   [Full Text] [Related]  

  • 35. Single agent cephalosporin prophylaxis for penetrating abdominal trauma. Results and comment on the emergence of the enterococcus.
    Feliciano DV; Gentry LO; Bitondo CG; Burch JM; Mattox KL; Cruse PA; Jordan GL
    Am J Surg; 1986 Dec; 152(6):674-81. PubMed ID: 3789294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Ward A; Richards DM
    Drugs; 1985 Nov; 30(5):382-426. PubMed ID: 3905336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of cefotetan versus cefoxitin plus metronidazole in the treatment of gynecological infections.
    Schwiersch U; Lang N
    Chemioterapia; 1987 Jun; 6(2 Suppl):541-2. PubMed ID: 3334618
    [No Abstract]   [Full Text] [Related]  

  • 38. The conversion of cefoxitin usage to cefotetan: an interdisciplinary approach.
    Nightingale CH; Smith KS; Quintiliani R; Briceland LL; Cooper B
    Am J Surg; 1988 May; 155(5A):101-2. PubMed ID: 3163897
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of single-dose moxalactam and a three-dose regimen of cefoxitin for prophylaxis in vaginal hysterectomy.
    Rapp RP; Connors JE; Hager WD; Donaldson ES; van Nagell JR
    Clin Pharm; 1986 Dec; 5(12):988-93. PubMed ID: 3542346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of intraabdominal infection with moxalactam.
    Murphy TF; Barza M
    Rev Infect Dis; 1982; 4 Suppl():S670-5. PubMed ID: 6218581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.